Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment

NCT06411210 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Diabetes type1
Obesity

Interventions

DRUG: Semaglutide Pen Injector
DRUG: Placebo

Sponsor

Yale University

Collaborators

[object Object]
[object Object]